Search

Your search keyword '"Dabis, F"' showing total 94 results

Search Constraints

Start Over You searched for: Author "Dabis, F" Remove constraint Author: "Dabis, F" Topic business.industry Remove constraint Topic: business.industry
94 results on '"Dabis, F"'

Search Results

1. Risk for non-AIDS-defining and AIDS-defining cancer of early versus delayed initiation of antiretroviral therapy

2. Delayed diagnosis of tuberculosis in persons living with HIV in Eastern Europe: associated factors and effect on mortality-a multicentre prospective cohort study

3. No need for secondary Pneumocystis jirovecii pneumonia prophylaxis in adult people living with HIV from Europe on ART with suppressed viraemia and a CD4 cell count greater than 100 cells/µL

4. Higher rates of triple-class virological failure in perinatally HIV-infected teenagers compared with heterosexually infected young adults in Europe

5. Low compliance with hepatocellular carcinoma screening guidelines in hepatitis B/C virus co-infected HIV patients with cirrhosis

6. Withholding Primary Pneumocystis Pneumonia Prophylaxis in Virologically Suppressed Patients With Human Immunodeficiency Virus: An Emulation of a Pragmatic Trial in COHERE

7. CD4/CD8 Ratio and the Risk of Kaposi Sarcoma or Non-Hodgkin Lymphoma in the Context of Efficiently Treated Human Immunodeficiency Virus (HIV) Infection: A Collaborative Analysis of 20 European Cohort Studies

8. Healthcare delivery for HIV-positive people with tuberculosis in Europe

9. Global temporal changes in the proportion of children with advanced disease at the start of combination antiretroviral therapy in an era of changing criteria for treatment initiation

10. Comparison of Kaposi Sarcoma Risk in Human Immunodeficiency Virus-Positive Adults Across 5 Continents: A Multiregional Multicohort Study

11. Reference curves for CD4 T-cell count response to combination antiretroviral therapy in HIV-1-infected treatment-naïve patients

12. Mortality in migrants living with HIV in western Europe (1997–2013): a collaborative cohort study

13. Global Trends in CD4 Cell Count at the Start of Antiretroviral Therapy: Collaborative Study of Treatment Programs

14. Daily cannabis and reduced risk of steatosis in human immunodeficiency virus and hepatitis C virus-co-infected patients (ANRS CO13-HEPAVIH)

15. Gender differences in the use of cardiovascular interventions in HIV-positive persons; the D:A:D study

16. Liver-related death among HIV/hepatitis C virus-co-infected individuals

17. Improved darunavir genotypic mutation score predicting treatment response for patients infected with HIRaben-1 subtype B and non-subtype B receiving a salvage regimen

18. Long-term mortality in HIV-positive individuals virally suppressed for >3 years with incomplete CD4 recovery

19. Triple therapy with boceprevir or telaprevir in a European cohort of cirrhotic HIV/HCV genotype 1-coinfected patients

20. Predictors of CD4(+) T-cell counts of HIV type 1-infected persons after virologic failure of all 3 original antiretroviral drug classes

21. Long-term effectiveness of unboosted atazanavir plus abacavir/lamivudine in subjects with virological suppression : A prospective cohort study

22. Effect of ignoring the time of HIV seroconversion in estimating changes in survival over calendar time in observational studies: results from CASCADE

23. Infection-related and -unrelated malignancies, HIV and the aging population

24. Tuberculosis-related mortality in people living with HIV in Europe and Latin America: An international cohort study

25. Implementation of Tuberculosis Intensive Case Finding, Isoniazid Preventive Therapy, and Infection Control ('Three I's') and HIV-Tuberculosis Service Integration in Lower Income Countries

26. Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estimated glomerular filtration rate: a prospective international cohort study

27. All-cause mortality in treated HIV-infected adults with CD4 ≥500/mm3 compared with the general population: evidence from a large European observational cohort collaboration

28. Tuberculosis among HIV-positive patients across Europe: changes over time and risk factors

29. Tolerance and viral resistance after single-dose nevirapine with tenofovir and emtricitabine to prevent vertical transmission of HIV-1

30. An assessment of the understanding of the offer of routine HIV testing among pregnant women in rural Zimbabwe

31. Non-AIDS defining cancers in the D:A:D Study--time trends and predictors of survival: a cohort study

32. Hyaluronic acid levels predict risk of hepatic encephalopathy and liver-related death in HIV/viral hepatitis coinfected patients

33. Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study

34. Does rapid HIV disease progression prior to combination antiretroviral therapy hinder optimal CD4 + T-cell recovery once HIV-1 suppression is achieved?

35. Improved knowledge and practices among end-users of mother-to-child transmission of HIV prevention services in rural Zimbabwe

36. Combination antiretroviral therapy and the risk of myocardial infarction

37. Field Evaluation of an Improved Assay Using a Heat-Dissociated p24 Antigen for Adults Mainly Infected With HIV-1 CRF02_AG Strains in C??te d'Ivoire, West Africa

38. HIV prevention in Latin America: Reaching youth in Colombia

39. 15 Month follow up of African children following vaginal cleansing with benzalkonium chloride of their HIV infected mothers during late pregnancy and delivery

40. Variable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy : not all AIDS-defining conditions are created equal

41. Cannabis Use and Reduced Risk of Insulin Resistance in HIV-HCV Infected Patients: A Longitudinal Analysis (ANRS CO13 HEPAVIH)

42. Detection and management of drug-resistant tuberculosis in HIV-infected patients in lower-income countries

43. Antiretroviral therapy response among HIV-2 infected patients: a systematic review

44. Short- and long-term mortality and causes of death in HIV/tuberculosis patients in Europe

45. Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration

46. Serum Triglycerides, HIV Infection, and Highly Active Antiretroviral Therapy, Aquitaine Cohort, France, 1996 to 1998

47. Dual Nucleoside Regimens in Nonadvanced HIV Infection: Prospective Follow-Up of 130 Patients, Aquitaine Cohort, 1996 to 1998

48. Letters to the Editor

49. Cervical dysplasia and HIV type 1 infection in African pregnant women: a cross sectional study, Kigali, Rwanda. The Pregnancy and HIV Study Group (EGE)

50. Effect of Gender, Age, Transmission Category, and Antiretroviral Therapy on the Progression of Human Immunodeficiency Virus Infection Using Multistate Markov Models

Catalog

Books, media, physical & digital resources